Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James M. Mock currently holds 2,906 shares of Moderna, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James M. Mock has been a net seller of MRNA stock. They have purchased $0 and sold $3.5M worth of shares.
James M. Mock's most recent insider trade was on Apr 2, 2026, when they sold 1,453 shares at $0.00 per share.
James M. Mock serves as Executive at Moderna, Inc. (MRNA). They have executed 90 insider transactions totaling $3.5M over their tenure at the company.
James M. Mock holds the position of Executive at Moderna, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
James M. Mock has shown a selling trading pattern, with $0 in total purchases and $3.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James M. Mock was on Dec 5, 2025, when they sold $581.6K worth of MRNA shares. This transaction involved 22,817 shares at $25.49 per share.
James M. Mock currently owns 2,906 shares of Moderna, Inc. (MRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James M. Mock's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James M. Mock has 90 Form 4 filings on record as an insider at Moderna, Inc..
Set alerts for James M. Mock and 40,000+ other insiders.